Internalized stress may be an overlooked driver of memory decline in aging populations. Stress internalization may quietly accelerate memory loss in older Chinese…
Newleos Therapeutics announced that the first participant has been dosed in the company's third Phase 1b study of NTX-1955, designed to evaluate its safety and…
Residential addiction treatment in America is fraught with exploitation, fraud, abuse, and preventable deaths, according to journalist Shoshana Walter's investigation…
Major Depressive Disorder affects many patients seeking behavioral healthcare treatment. According to AltaPointe Health, a system serving 45,000 patients, research…
U.S. Health and Human Services Secretary Robert F. Kennedy Jr. has praised Italy's San Patrignano addiction treatment program as a model that should be replicated in…
A 44-year-old man who spent 31 years living with severe, treatment-resistant depression alongside PTSD and panic disorder experienced significant improvement through an…
A surge in counterfeit prescription pills and emerging synthetic compounds is intensifying the drug crisis in the United States, according to officials testifying before…
Virginia Tech researchers are advancing a new generation of vaccines designed to block opioids from reaching the brain and triggering their addictive effects. Research…
Fentanyl and other synthetic opioids have driven the worst drug crisis in U.S. history, with profound consequences for public health, the economy, and national security.…
A growing body of research suggests that GLP-1 medications, known primarily for weight loss, can significantly help people suffering from substance abuse disorders get…
San Mateo County residents held a heated community meeting Tuesday night to discuss a proposed 69-bed substance abuse treatment center operated by Horizon Services. The…
California Department of Corrections and Rehabilitation officials are investigating the death of an incarcerated person at Substance Abuse Treatment Facility in Corcoran…
Alan G. Brackett and Lejla Alibasic of Mouledoux, Bland, Legrand & Brackett discuss the development of workers compensation legislation to cover not only physical…
(MedPage Today) -- An individualized dosing regimen of the inhaled psychedelic mebufotenin (GH001) led to significant improvements in depression symptoms in patients…
LONDON & NEW YORK--(BUSINESS WIRE) $CMPS Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based…
EINPresswire/ -- Madorra Inc., a medical device company developing innovative solutions for menopause-related conditions, today announced the enrollment of the first…
This article reviews the evidence for magnesium, riboflavin, CoQ10, feverfew, vascular tone, and oxidative balance. It also highlights the growing field of nutritional…
Tennessee Health Board Disciplinary Actions: Middle Tennessee Practitioners — January 2026 The Tennessee Department of Health released its monthly disciplinary action…
More than 48 million Americans are battling substance use disorder. Many are deteriorating in plain sight — on sidewalks, in encampments, and in emergency rooms. Others…
St. Bernards Medical Center announced its participation in Goldfinch Health’s “Billion Pill Pledge” on Friday, becoming the first hospital in Arkansas to launch a…
He was 17 years old, a serious football injury put him under the knife for surgery and sent him home with a 60-pill script for oxycodone to manage pain. Three scripts…
Mental health professionals recognize problematic gambling as an addiction. Should the same apply to excessive gaming, compulsive sexual behavior and problematic social…
A new review in The Lancet Psychiatry finds little evidence that marijuana reduces symptoms of anxiety, depression or PTSD while many users self‐medicate.
Nashville, TN, March 18, 2026 (GLOBE NEWSWIRE) -- Sober Sessions is redefining the live music experience by creating a space where music, community, and recovery…
NRx Pharmaceuticals (NASDAQ: NRXP) announced it received a letter from the FDA's Bioequivalence Program stating no bioequivalence deficiencies were identified at ...
Cingulate Inc., a biopharmaceutical company developing ADHD treatments using its proprietary Precision Timed Release (PTR) drug delivery platform, reported fourth…
Some researchers and recovery advocates see the NET device as the latest in a series of products pitched as the solution to the addiction crisis that have been overhyped…
Determination of bioequivalence to the Reference Listed Drug is essential for approval of an Abbreviated New Drug Application (ANDA). FDA has advised NRx in ...
Life is stressful, but there's something you can do about it right now—and it's easy! Here's how to improve your mood in just a few minutes. The post Stressed Out? This…